全文获取类型
收费全文 | 238106篇 |
免费 | 41119篇 |
国内免费 | 8427篇 |
专业分类
耳鼻咽喉 | 5838篇 |
儿科学 | 6781篇 |
妇产科学 | 3227篇 |
基础医学 | 11458篇 |
口腔科学 | 3295篇 |
临床医学 | 38528篇 |
内科学 | 57578篇 |
皮肤病学 | 8403篇 |
神经病学 | 18027篇 |
特种医学 | 9492篇 |
外国民族医学 | 27篇 |
外科学 | 48975篇 |
综合类 | 19792篇 |
现状与发展 | 98篇 |
一般理论 | 3篇 |
预防医学 | 14516篇 |
眼科学 | 5441篇 |
药学 | 11046篇 |
106篇 | |
中国医学 | 7196篇 |
肿瘤学 | 17825篇 |
出版年
2024年 | 1084篇 |
2023年 | 6272篇 |
2022年 | 5121篇 |
2021年 | 7912篇 |
2020年 | 9905篇 |
2019年 | 4885篇 |
2018年 | 10184篇 |
2017年 | 10347篇 |
2016年 | 11014篇 |
2015年 | 12581篇 |
2014年 | 20618篇 |
2013年 | 20983篇 |
2012年 | 13047篇 |
2011年 | 13791篇 |
2010年 | 16491篇 |
2009年 | 19290篇 |
2008年 | 11487篇 |
2007年 | 9354篇 |
2006年 | 11437篇 |
2005年 | 8096篇 |
2004年 | 5949篇 |
2003年 | 4522篇 |
2002年 | 4085篇 |
2001年 | 5368篇 |
2000年 | 4400篇 |
1999年 | 4348篇 |
1998年 | 4257篇 |
1997年 | 4081篇 |
1996年 | 3816篇 |
1995年 | 3614篇 |
1994年 | 2341篇 |
1993年 | 1770篇 |
1992年 | 1588篇 |
1991年 | 1586篇 |
1990年 | 1249篇 |
1989年 | 1298篇 |
1988年 | 1134篇 |
1987年 | 963篇 |
1986年 | 950篇 |
1985年 | 781篇 |
1984年 | 569篇 |
1983年 | 533篇 |
1982年 | 527篇 |
1981年 | 415篇 |
1980年 | 364篇 |
1979年 | 324篇 |
1978年 | 330篇 |
1977年 | 398篇 |
1975年 | 278篇 |
1972年 | 302篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
62.
63.
Platelet function has been described by many laboratory assays, and PL-11 is a new point-of-care platelet function analyzer based on platelet count drop method, which counts platelet before and after the addition of agonists in the citrated whole blood samples. The present study sought to compare PL-11 with other three major more established assays, light transmission aggregometry (LTA), VerifyNow? aspirin system and thromboelastography (TEG), for monitoring the short-term aspirin responses in healthy individuals. Ten healthy young men took 100?mg/d aspirin for 3-day treatment. Platelet function was measured via PL-11, LTA, VerifyNow and TEG, respectively. The blood samples were collected at baseline, 2 hour, 1 day during the aspirin treatment and 1 day, 5?±?1 days, 8?±?1 days after the aspirin withdrawal. Moreover, 90 additional healthy subjects were recruited to establish a reference range for PL-11. Platelet function of healthy subjects decreased significantly 2 hours after 100?mg/d aspirin intake and began to recover during 4–6 days after the aspirin withdrawal. Correlations between methods were PL-11 vs. LTA (r?=?0.614, p?<?0.01); PL-11 vs. VerifyNow (r?=?0.829, p?<?0.01); PL-11 vs. TEG (r?=?0.697, p?<?0.001). There was no significant bias between PL-11 and LTA at baseline (bias?=?1.94%, p?=?0.804) using Bland-Altman analysis, while the data of PL-11 were significantly higher than LTA (bias?=?24.02%, p?<?0.001) during the aspirin therapy. The reference range for PL-11 in healthy young individuals was from 66.8 to 90.5% (95%CI). When aspirin low-responsiveness was defined as LTA?>?20%, the cut-off values for each method were, respectively: PL-11?>?50%, VerifyNow?>?533 ARU, TEG?>?60.2%. The results of different platelet function assays were uninterchangeable for monitoring aspirin response and correlations among them were also varied. Correlations among PL-11 and other three major assays suggested the ability of PL-11 to assess the treatment effects of aspirin. But a large cohort study is needed to confirm the cut-off value of aspirin response detected by PL-11. 相似文献
64.
Breast Elastography: How to Perform and Integrate Into a “Best-Practice” Patient Treatment Algorithm
Breast elastography has been available for more than 15 years but is not widely incorporated into clinical practice. Many publications report extremely high accuracy for various breast elastographic techniques. However, results in the literature are extremely variable. This variability is most likely due to variations in technique, a relatively steep learning curve, and variability in methods between vendors. This article describes our protocol for performing breast elastography using both strain elastography and shear wave elastography, which produces high sensitivity and specificity. Additionally, we will describe the most commonly known false-positive and false-negative lesions as well as how to detect them. 相似文献
65.
66.
67.
68.
69.
目的 研究血清窖蛋白-1 (Cav-1) 在慢性阻塞性肺疾病 (COPD) 相关肺动脉高压 (PAH) 患者中的表达及其意义。方法 选取稳定期COPD患者65例, 根据是否合并PAH分成COPD组 [肺动脉收缩压 (PASP) <40 mmHg, 35例] 及COPD-PAH组 (PASP ≥40 mmHg, 30例)。另选取在本院健康体检的志愿者30例作为对照组。对比各组基线资料、 动脉血气分析、 肺功能指标, 以及血清Cav-1、 白细胞介素 (IL) -6和肿瘤坏死因子-α (TNF-α) 的表达水平。绘制受试者工作特征 (ROC) 曲线, 评价Cav-1对COPD合并PAH的诊断价值。结果 COPD-PAH组与COPD组第一秒用力呼吸容积 (FEV1) /用力肺活量 (FVC)、 FEV1占预计值百分比 (FEV1%) 及氧分压 [p (O2 )] 低于对照组, 而二氧化碳分压 [p (CO2 )]、 PASP均高于对照组 (P<0.01)。COPD-PAH组p (O2 ) 低于COPD组, p (CO2 )、 PASP均高于COPD 组 (P<0.01)。对照组、 COPD组及COPD-PAH组Cav-1表达水平呈逐渐降低趋势, 而IL-6、 TNF-α表达水平呈逐渐升高趋势 (P<0.01)。血清Cav-1诊断COPD合并PAH的ROC曲线下面积为0.902 (0.821~0.955), 最佳截断值为 6.66 μg/L, 此时诊断敏感度为76.7%, 特异度为85.7%, 与多普勒超声诊断仪测量PASP结果比较一致性较好 (Kappa 值=0.627)。结论 血清Cav-1在COPD相关PAH患者表达明显下调, 可以作为预测COPD相关PAH的新型血清标志物。 相似文献